N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma

N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma

Abstract Background Vulvar squamous cell carcinoma (VSCC) is an uncommon gynecologic malignancy but with an increasing incidence in recent years. Etiologically, VSCC is classified into two subtypes: HPV-dependent and HPV-independent. Localized VSCC is treated surgically and/or with radiation therapy...

Full description

Bibliographic Details
Main Authors: Mateja Condic, Thore Thiesler, Christian Staerk, Niklas Klümper, Jörg Ellinger, Eva K. Egger, Kirsten Kübler, Glen Kristiansen, Alexander Mustea, Damian J. Ralser
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Cancer
Subjects:
m6A
N6-methyladenosine RNA modification
Vulvar squamous cell carcinoma
HPV
Biomarker
Online Access:https://doi.org/10.1186/s12885-022-10010-x

Internet

https://doi.org/10.1186/s12885-022-10010-x

Similar Items